Stay updated on RC48-ADC in HER2+ Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in HER2+ Biliary Cancer Clinical Trial page.

Latest updates to the RC48-ADC in HER2+ Biliary Cancer Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.7.2 instead of v3.7.1. The study record content appears unchanged.SummaryDifference0.1%

- Check13 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry v3.7.0 has been added to the study record history, and the previous revision v3.6.6 is removed from the list. This update reflects changes to the version history rather than to the core trial data.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision v3.6.6 has been added to the study record history, and the previous revision v3.6.5 has been removed, reflecting an update to the record since the last version.SummaryDifference0.1%

- Check76 days agoChange DetectedThe record history now reflects the latest platform revision v3.6.5, replacing the previous v3.6.4. This is an administrative update recorded in the page history, with no change to study data or core content.SummaryDifference0.1%

- Check91 days agoChange DetectedNew revision entry Revision: v3.6.4 was added to the record history, and the previous Revision: v3.6.3 entry was removed. This reflects a small update to the page's history log rather than changes to the study content.SummaryDifference0.1%

Stay in the know with updates to RC48-ADC in HER2+ Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Biliary Cancer Clinical Trial page.